COVID-19: Factors associated with psychological distress, fear, and coping strategies among community members across 17 countries.


Journal

Globalization and health
ISSN: 1744-8603
Titre abrégé: Global Health
Pays: England
ID NLM: 101245734

Informations de publication

Date de publication:
01 10 2021
Historique:
received: 28 06 2021
accepted: 20 09 2021
entrez: 2 10 2021
pubmed: 3 10 2021
medline: 7 10 2021
Statut: epublish

Résumé

The current pandemic of COVID-19 impacted the psychological wellbeing of populations globally. We aimed to examine the extent and identify factors associated with psychological distress, fear of COVID-19 and coping. We conducted a cross-sectional study across 17 countries during Jun-2020 to Jan-2021. Levels of psychological distress (Kessler Psychological Distress Scale), fear of COVID-19 (Fear of COVID-19 Scale), and coping (Brief Resilient Coping Scale) were assessed. A total of 8,559 people participated; mean age (±SD) was 33(±13) years, 64% were females and 40% self-identified as frontline workers. More than two-thirds (69%) experienced moderate-to-very high levels of psychological distress, which was 46% in Thailand and 91% in Egypt. A quarter (24%) had high levels of fear of COVID-19, which was as low as 9% in Libya and as high as 38% in Bangladesh. More than half (57%) exhibited medium to high resilient coping; the lowest prevalence (3%) was reported in Australia and the highest (72%) in Syria. Being female (AOR 1.31 [95% CIs 1.09-1.57]), perceived distress due to change of employment status (1.56 [1.29-1.90]), comorbidity with mental health conditions (3.02 [1.20-7.60]) were associated with higher levels of psychological distress and fear. Doctors had higher psychological distress (1.43 [1.04-1.97]), but low levels of fear of COVID-19 (0.55 [0.41-0.76]); nurses had medium to high resilient coping (1.30 [1.03-1.65]). The extent of psychological distress, fear of COVID-19 and coping varied by country; however, we identified few higher risk groups who were more vulnerable than others. There is an urgent need to prioritise health and well-being of those people through well-designed intervention that may need to be tailored to meet country specific requirements.

Sections du résumé

BACKGROUND
The current pandemic of COVID-19 impacted the psychological wellbeing of populations globally.
OBJECTIVES
We aimed to examine the extent and identify factors associated with psychological distress, fear of COVID-19 and coping.
METHODS
We conducted a cross-sectional study across 17 countries during Jun-2020 to Jan-2021. Levels of psychological distress (Kessler Psychological Distress Scale), fear of COVID-19 (Fear of COVID-19 Scale), and coping (Brief Resilient Coping Scale) were assessed.
RESULTS
A total of 8,559 people participated; mean age (±SD) was 33(±13) years, 64% were females and 40% self-identified as frontline workers. More than two-thirds (69%) experienced moderate-to-very high levels of psychological distress, which was 46% in Thailand and 91% in Egypt. A quarter (24%) had high levels of fear of COVID-19, which was as low as 9% in Libya and as high as 38% in Bangladesh. More than half (57%) exhibited medium to high resilient coping; the lowest prevalence (3%) was reported in Australia and the highest (72%) in Syria. Being female (AOR 1.31 [95% CIs 1.09-1.57]), perceived distress due to change of employment status (1.56 [1.29-1.90]), comorbidity with mental health conditions (3.02 [1.20-7.60]) were associated with higher levels of psychological distress and fear. Doctors had higher psychological distress (1.43 [1.04-1.97]), but low levels of fear of COVID-19 (0.55 [0.41-0.76]); nurses had medium to high resilient coping (1.30 [1.03-1.65]).
CONCLUSIONS
The extent of psychological distress, fear of COVID-19 and coping varied by country; however, we identified few higher risk groups who were more vulnerable than others. There is an urgent need to prioritise health and well-being of those people through well-designed intervention that may need to be tailored to meet country specific requirements.

Identifiants

pubmed: 34598720
doi: 10.1186/s12992-021-00768-3
pii: 10.1186/s12992-021-00768-3
pmc: PMC8485312
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

117

Informations de copyright

© 2021. The Author(s).

Références

PLoS One. 2020 Dec 11;15(12):e0243962
pubmed: 33306750
EClinicalMedicine. 2020 Dec;29:100630
pubmed: 33200120
Int J Environ Res Public Health. 2020 May 02;17(9):
pubmed: 32370116
J Public Health (Oxf). 2020 Aug 18;42(3):504-509
pubmed: 32436578
Global Health. 2020 Oct 8;16(1):95
pubmed: 33032629
PLoS One. 2021 Apr 1;16(4):e0249453
pubmed: 33793663
Int J Environ Res Public Health. 2020 Jun 29;17(13):
pubmed: 32610613
J Affect Disord. 2020 Oct 1;275:69-77
pubmed: 32658826
Psychol Med. 2003 Feb;33(2):357-62
pubmed: 12622315
PLoS One. 2020 Dec 31;15(12):e0244809
pubmed: 33382859
J Womens Health (Larchmt). 2020 Apr;29(4):465-466
pubmed: 32320331
Cyberpsychol Behav Soc Netw. 2021 Aug;24(8):521-525
pubmed: 33601944
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
J Psychopharmacol. 2010 Nov;24(4 Suppl):61-8
pubmed: 20923921
Int J Biol Sci. 2020 Aug 27;16(15):2828-2834
pubmed: 33061799
Front Psychol. 2021 Apr 06;12:601732
pubmed: 33889105
Int J Environ Res Public Health. 2020 Sep 30;17(19):
pubmed: 33007892
Brain Behav Immun. 2020 Aug;88:901-907
pubmed: 32437915
PLoS One. 2021 Feb 11;16(2):e0246824
pubmed: 33571297
Int J Ment Health Addict. 2020 Mar 27;:1-9
pubmed: 32226353
Sci Rep. 2021 May 13;11(1):10173
pubmed: 33986414
JAMA Netw Open. 2020 Mar 2;3(3):e203976
pubmed: 32202646
Scand J Psychol. 2020 Oct;61(5):698-706
pubmed: 32567696
Lancet. 2020 Mar 14;395(10227):912-920
pubmed: 32112714
Int J Environ Res Public Health. 2020 Jun 07;17(11):
pubmed: 32517294
J Psychiatr Res. 2021 Apr;136:103-108
pubmed: 33582608
BMC Public Health. 2021 Jan 9;21(1):104
pubmed: 33422039
N Engl J Med. 2020 Aug 6;383(6):510-512
pubmed: 32283003
J Behav Ther Exp Psychiatry. 2009 Mar;40(1):3-14
pubmed: 18417098
Int J Ment Health Nurs. 2021 Jun;30(3):747-758
pubmed: 33555128
Assessment. 2004 Mar;11(1):94-101
pubmed: 14994958
Arch Womens Ment Health. 2020 Dec;23(6):749-756
pubmed: 33068161

Auteurs

Muhammad Aziz Rahman (MA)

School of Health, Federation University Australia, Berwick, Victoria, Australia. ma.rahman@federation.edu.au.
Australia Institute for Primary Care and Ageing (AIPCA), La Trobe University, Melbourne, Victoria, Australia. ma.rahman@federation.edu.au.
Department of Noncommunicable Diseases, Bangladesh University of Health Sciences (BUHS), Dhaka, Bangladesh. ma.rahman@federation.edu.au.

Sheikh Mohammed Shariful Islam (SMS)

Deakin University, Burwood, Victoria, Australia.

Patraporn Tungpunkom (P)

Faculty of Nursing, Chiang Mai University, Chiang Mai, Thailand.

Farhana Sultana (F)

Telstra Health, Melbourne, Victoria, Australia.

Sheikh M Alif (SM)

Monash University, Clayton, Victoria, Australia.

Biswajit Banik (B)

School of Health, Federation University Australia, Berwick, Victoria, Australia.

Masudus Salehin (M)

School of Health, Federation University Australia, Berwick, Victoria, Australia.

Bindu Joseph (B)

School of Health, Federation University Australia, Berwick, Victoria, Australia.

Louisa Lam (L)

School of Health, Federation University Australia, Berwick, Victoria, Australia.

Mimmie Claudine Watts (MC)

School of Health, Federation University Australia, Berwick, Victoria, Australia.

Sabria Jihan Khan (SJ)

The University of Melbourne, Melbourne, Victoria, Australia.

Sherief Ghozy (S)

Neurovascular Research Lab, Radiology Department, Mayo Clinic, Rochester, MN, USA.

Sek Ying Chair (SY)

The Nethersole School of Nursing, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong.

Wai Tong Chien (WT)

The Nethersole School of Nursing, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong.

Carlos Schönfeldt-Lecuona (C)

Psychiatric University Clinic Ulm, Ulm, Germany.

Nashwa El-Khazragy (N)

Faculty of Medicine, Ain Shams University, Cairo, Egypt.

Ilias Mahmud (I)

Department of Public Health, College of Public Health and Health Informatics, Qassim University, Al Bukairiyah, Kingdom of Saudi Arabia.

Adhra Hilal Al Mawali (AH)

Ministry of Health, Muscat, Sultanate of Oman.

Turkiya Saleh Al Maskari (TS)

Oman College of Health Sciences-South Sharquiya, Sur, Sultanate of Oman.

Rayan Jafnan Alharbi (RJ)

Department of Emergency Medical Service, Jazan University, Jazan, Kingdom of Saudi Arabia.

Amr Hamza (A)

Faculty of Medicine, University of Aleppo, Aleppo, Syria.

Mohamad Ali Keblawi (MA)

Faculty of Medicine, University of Aleppo, Aleppo, Syria.

Majeda Hammoud (M)

Faculty of Medicine, Kuwait University, Kuwait City, Kuwait.

Asmaa M Elaidy (AM)

Faculty of Medicine for Girls, Al-azhar University, Cairo, Egypt.

Agus Dwi Susanto (AD)

Department of Pulmonology and Respiratory Medicine, Universitas Indonesia, Jakarta, Indonesia.

Ahmed Suparno Bahar Moni (AS)

Advanced Medical and Dental Institute, Universiti Sains Malaysia, Penang, Malaysia.

Alaa Ashraf AlQurashi (AA)

King Fahad Medical City, Riyadh, Kingdom of Saudi Arabia.

Almajdoub Ali (A)

Brega General Hospital, Brega, Libya.

Amit Wazib (A)

Enam Medical College & Hospital, Dhaka, Bangladesh.

Cattaliya Siripattarakul Sanluang (CS)

Faculty of Nursing, Chiang Mai University, Chiang Mai, Thailand.

Deena H Elsori (DH)

Abu Dhabi University, Abu Dhabi, United Arab Emirates.

Farhana Yasmin (F)

Lahore Garrison University, Lahore, Pakistan.

Feni Fitrani Taufik (FF)

Department of Pulmonology and Respiratory Medicine, Universitas Indonesia, Jakarta, Indonesia.

Manal Al Kloub (M)

The Hashemite University, Zarqa, Jordan.

Mara Gerbabe Ruiz (MG)

Oman College of Health Sciences-South Sharquiya, Sur, Sultanate of Oman.

Mohamed Elsayed (M)

Department of Psychiatry and Psychotherapy, University of Ulm, Ulm, Germany.

Nael Kamel Eltewacy (NK)

Faculty of Pharmacy, Beni-Suef University, Minia, Egypt.

Nahed Al Laham (N)

Al Azhar University-Gaza, Gaza strip, Palestine.

Natalia Oli (N)

Kathmandu Medical College, Kathmandu, Nepal.

Ramy Abdelnaby (R)

Department of Neurology, RWTH Aachen University, Aachen, Germany.

Rania Dweik (R)

Abu Dhabi University, Abu Dhabi, United Arab Emirates.

Ratree Thongyu (R)

Rangsit University, Pathum Thani, Thailand.

Sami Almustanyir (S)

Ministry of Health, Riyadh, Kingdom of Saudi Arabia.

Shaila Rahman (S)

Enam Medical College & Hospital, Dhaka, Bangladesh.

Sirirat Nitayawan (S)

Faculty of Nursing, Chiang Mai University, Chiang Mai, Thailand.

Sondos Al-Madhoun (S)

Al Azhar University-Gaza, Gaza strip, Palestine.

Suwit Inthong (S)

Faculty of Nursing, Chiang Mai University, Chiang Mai, Thailand.

Talal Ali Alharbi (TA)

King Saud University Medical City, King Saud University, Riyadh, Kingdom of Saudi Arabia.

Tamanna Bahar (T)

National Institute of Cancer Research and Hospital, Dhaka, Bangladesh.

Tribowo Tuahta Ginting (TT)

Psychiatric Medical Staff Group, Persahabatan General Hospital, Jakarta, Indonesia.

Wendy M Cross (WM)

School of Health, Federation University Australia, Berwick, Victoria, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH